Point-of-care prothrombin time testing in paediatric intensive care: an observational study of the ease of use of

Natalie Urwyler1, Eveline Staub, Lukas P Staub

  • 1Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA. urwyler@stanford.edu

Insights

Point-of-care prothrombin time testing in pediatric intensive care offers advantages. The CoaguChek XS Plus demonstrated good agreement with lab standards, unlike CoaLine, making it suitable for pediatric use.

Area of Science:

  • Clinical Chemistry
  • Pediatric Critical Care Medicine
  • Point-of-Care Testing

Background:

  • Pediatric blood sampling faces challenges with venous access and sample volume.
  • Accurate prothrombin time (PT) monitoring is crucial in pediatric intensive care units (ICUs).

Purpose of the Study:

  • To evaluate the clinical utility of two point-of-care (POC) PT testing devices in pediatric ICU patients.
  • To assess the ease of use and correlation of POC PT results with standard laboratory measurements.

Main Methods:

  • A single-center observational study was conducted in a tertiary center's pediatric ICU.
  • Thirty-eight pediatric patients (0-13 years) were included to assess the CoaguChek XS Plus and CoaLine devices.
  • Ease of use and agreement between POC and laboratory PT measurements were evaluated.

Main Results:

  • CoaguChek XS Plus had a 2% failure rate, CoaLine 17%, and the lab standard 4%.
  • CoaguChek XS Plus showed better ease of use ratings by personnel.
  • CoaguChek XS Plus demonstrated good agreement (r=0.79) and CoaLine moderate agreement (r=0.72) with laboratory PT standards, despite observed variability.

Conclusions:

  • CoaguChek XS Plus offers good agreement for PT testing in pediatric ICUs.
  • POC PT testing in pediatrics provides rapid results and reduces blood volume requirements.
  • CoaguChek XS Plus is a valuable tool for PT monitoring in pediatric critical care settings.
Abstract